Randomised controlled trial of first-line tyrosine-kinase inhibitor (TKI) versus inte... | RTCL.TV
Channel: Medicine RTCL TV
Date: 2023-09-24

### Keywords ###
#weightloss #NSCLC #anorexia #mutatednonsmall #lungcancer #renaltoxicity #EGFR #RTCLTV #shorts

### Article Attribution ###
Title: Randomised controlled trial of first-line tyrosine-kinase inhibitor (TKI) versus intercalated TKI with chemotherapy for EGFR-mutated nonsmall cell lung cancer
Authors: Rolof G.P. Gijtenbeek, Vincent van der Noort, Joachim G.J.V. Aerts, Jeske A. Staal-van den Brekel, Egbert F. Smit, Frans H. Krouwels, Frank A. Wilschut, T. Jeroen N. Hiltermann, Wim Timens, Ed Schuuring, Joost D.J. Janssen, Martijn Goosens, Paul M. van den Berg, A. Joop de Langen, Jos A. Stigt, Ben E.E.M. van den Borne, Harry J.M. Groen, Wouter H. van Geffen ,and Anthonie J. van der Wekken
Publisher: European Respiratory Society
DOI: 10.1183/23120541.00239-2022
DOAJ URL: https://doaj.org/article/7a4d1f9500d043fca5a9dd6a08afeeba
Source URL: http://openres.ersjournals.com/content/8/4/00239-2022.full



### Image Attribution ###
We used stable diffusion to programmatically generate the background images. 
Viewer discretion is advised.

### Channels ###
YouTube Channel: https://www.youtube.com/@medicinertcltv
Odysee Channel: https://odysee.com/@medicine_rtcl_tv

### Video Timestamps ###
0:00:00 - Summary 
0:00:16 - Title 
0:00:24 - End